Igama lemveliso:I-N-Methyl-DL-Aspartic Acid
Inombolo yeCAS:17833-53-3
Elinye Igama:N-methyl-D,L-aspartate;
N-methyl-D, L-aspartic acid;
L-Aspartic acid, N-methyl;
I-DL-Aspartic acid, i-N-methyl;
I-DL-2-METHYLAMINOSUCCINIC ACID;
Iinkcukacha: 98.0%
Umbala: Umgubo omhlophe onevumba elibonakalayo kunye nencasa
Isimo se-GMO:GMO Mahala
Ukupakisha: kwi-25kgs fiber drums
Ugcino: Gcina isikhongozeli singavulwanga kwindawo epholileyo neyomileyo, Zigcine kude nokukhanya okuqinileyo
Ubomi beShelf: iinyanga ezingama-24 ukusuka kumhla wokuvelisa
I-N-Methyl-DL-Aspartic Acid (NMA) |NMDAI-Receptor agonist yoPhando lweNeuroscience
IKhowudi yeMveliso: NMA-2025 | I-CAS:17833-53-3| Ubunyulu: ≥98%
Product Overview
I-N-Methyl-DL-Aspartic Acid (NMA), eyaziwa ngokuba yi-DL-2-Methylaminosuccinic Acid, i-analogue ye-glutamate yokwenziwa kunye ne-NMDA enamandla ye-receptor agonist. Isetyenziswa ngokubanzi kuphando lwe-neurobiological ukufunda iplastiki ye-synaptic, i-neuronal excitotoxicity, kunye nemizekelo yezifo ezinjengeentlungu ze-neuropathic kunye nokuwohloka kweretina.
Ezona mpawu
- Ubunyulu obuPhezulu: Kuvavanywa ngokungqongqo nge-HPLC (≥98% ukucoceka) ukuqinisekisa ukuhambelana kwiziphumo zovavanyo.
- Usetyenziso oluguquguqukayo: Ilungelei-In vitrokwayekwi vivoizifundo, kubandakanywa i-fictive locomotion induction kuthungelwano lwe-spinal cord, i-maternal behaviour ye-neural circuitry analysis, kunye ne-retinal damage modeling.
- UkuThotyelwa kweMigangatho yeHlabathi: Kufunyenwe kumaziko aqinisekisiweyo e-ISO, anokulandeleka ngokupheleleyo kunye namaxwebhu e-MSDS.
Izicelo kuPhando
- I-Neuropharmacology:
- Ikhupha i-fictive locomotion kwiintambo zomqolo ezizimeleyo xa zidibene kunye ne-5-HT (umzekelo, i-10 µM NMA + 10 µM 5-HT) .
- Iququzelela ukusebenza kwe-NMDA receptor kwizifundo ze-excitotoxicity kunye neuroprotection.
- I-Neuroscience yokuziphatha:
- Isetyenziswa kwizilonda ze-excitotoxic (umzekelo, ukukhutshwa kwe-MPOA) ukuphanda iindlela zokuziphatha komama.
- Umzekelo weSifo:
- Ibangela ukwehla kweeseli zeretina kwiimodeli zezilwanyana zokufunda ukuphazamiseka kwe-neurodeergenerative.
IiNgcaciso zobuGcisa
Ipharamitha | Iinkcukacha |
---|---|
Ifomula yeemolekyuli | C₅H₉NO₄ |
Ubunzima beMolekyuli | 147.13 g/mol |
Izithethantonye | I-DL-2-Methylaminosuccinic Acid, i-NMA |
Ugcino | Gcina kwi -20 ° C kwiimeko ezomileyo |
IiKhetho zokuPakisha | 10 mg, 50 mg, 100 mg (Inokwenzeka ngokwezifiso) |
Kutheni Khetha Thina?
- Iminyaka eyi-15+ yobuNgcali: Njengomthengisi othembekileyo kwiikhemikhali zophando, sibeka phambili impendulo ekhawulezayo kunye nezisombululo ezilungiselelwe abathengi bezemfundo kunye namashishini.
- Ukufikeleleka: Iinkcazo zeMveliso zakhiwe ngamagama angundoqo (I-agonist ye-NMDA, ikhemikhali yophando lwe-neuroscience) ukuphucula ukubonakala kuGoogle kunye nogcino lweenkcukacha zenzululwazi.
Iimveliso ezinxulumeneyo
- I-5-Hydroxytryptamine (5-HT): Ukusetyenziswa kwe-Synergistic kunye ne-NMA kwizifundo ze-locomotion.
- I-Calcium 2AEP kunye ne-Astaxanthin: Phonononga ipotifoliyo yethu ye-neuroprotective compound.